Patients with Rare Diseases Face Insurer Barriers that Can Limit Treatment


Patients with rare diseases or preexisting conditions have faced increasing difficulty getting their health insurers to approve treatments, whether through treatment interruption or through treatment denial. Insurance companies sometimes requires patients to stop taking their medications or undergo new lab work to demonstrate they still need it after being prescribed certain medications. Read more here.


Comments are closed.